General News

Home/General News

Cutting NIH budget could cripple drug development

A proposal to slash funding for the National Institutes of Health (NIH) could severely impair the development of new, life-saving drugs, according to a new analysis by researchers at Washington University School of Medicine in St. Louis. NIH funding supports the early research needed to develop new, innovative drugs. President Donald Trump’s proposed budget calls

November 27th, 2017|Categories: Around The State, General News|Tags: , , |

Subset of Stem Cells Identified as Source for All Cells in Blood and Immune Systems

Researchers at Fred Hutchinson Cancer Research Center have identified a specific subset of adult blood stem cells that is exclusively responsible for repopulating the entire blood and immune system after a transplant. The discovery, to be published Nov. 1 in Science Translational Medicine, has the potential to revolutionize blood stem cell transplantation as well as the

November 16th, 2017|Categories: General News|Tags: , |

Three decades of responding to infectious disease outbreaks

Soon after his appointment in 1984 as director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, Anthony S. Fauci, M.D., testified before Congress showing a world map annotated with a single emerging infectious disease threat, HIV/AIDS. Since then, diseases and pathogens including chikungunya, H1N1 influenza, severe

November 15th, 2017|Categories: General News|Tags: |

Research: Vaccinating Against Psoriasis, Allergies and Alzheimer’s a Possibility

Research from the Universities of Dundee and Oxford has shown how combining the tetanus vaccine with a viral particle that normally affects cucumbers can be used to treat psoriasis and allergies, and may even protect against Alzheimer's disease. Scientists led by Dundee's Dr John Foerster and Oxford's Professor Martin Bachmann, were able to take the

Hep C Treatment Increasingly Feasible in Primary Care

With highly effective treatments for hepatitis C becoming less expensive, it is no longer necessary for subspecialists to treat most patients with this condition, delegates heard here at the International Conference on Viral Hepatitis 2017. "Primary care providers, when given the resources, do just as amazing a job as subspecialists," said Stacey Trooskin, MD, PhD,

October 19th, 2017|Categories: General News|Tags: |

New Class of Molecules Protect Neural Cell Integrity Upon Injury

Research led by Nicolas Bazan, MD, PhD, Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health New Orleans, has discovered a new class of molecules in the brain that synchronize cell-to-cell communication and neuroinflammation/immune activity in response to injury or diseases. Elovanoids (ELVs) are bioactive chemical messengers made from omega-3 very

October 15th, 2017|Categories: General News|Tags: , , , |

Virtual Brain Lab Brings Together World-leading Neuroscientists

Twenty-one leading neuroscience groups from around the world, including seven from UCL, have formed a "virtual brain lab" to test how the brain controls learning and decision making. The £10 million International Brain Lab brings together groups from UK, USA, France, Switzerland and Portugal to uncover how complex networks of brain cells support our ability to

October 14th, 2017|Categories: General News|Tags: , |

SLU Scientist: Hibernating Ribosomes Help Bacteria Survive

In the second of two high-profile articles published in recent weeks, Saint Louis University scientist Mee-Ngan F. Yap, Ph.D., in collaboration with the laboratories of 2009 Nobel laureate in chemistry Ada Yonath at the Weizmann Institute of Science and Alexey Amunts at Stockholm University, describe in Nature Communications new information about the structure of Staphylococcus

October 12th, 2017|Categories: Around The State, General News|Tags: , , |